Acute Ischemic Stroke
Conditions
Brief summary
This study employs individualized temperature health risk early warning and risk factor management interventions for stroke, and explores their actual intervention effects. This enables patients to promptly understand their own risk levels and take corresponding protective measures, thereby enhancing the management outcomes and quality of life. The study also promotes the interdisciplinary integration of environmental epidemiology and clinical intervention management, providing new ideas and methodological support for future relevant research.
Interventions
OTHERIndividualized temperature health risk early warning and risk factor management
Receive individualized temperature health risk warning and prevention risk factor management information for stroke through the application
Receive individualized temperature health risk warning through the application
Receive individualized prevention risk factor management information for stroke through the application
Sponsors
Xuanwu Hospital, Beijing
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Aged 40 to 80, with no gender restrictions; * Acute ischemic stroke inpatients within 2 weeks of onset, where the onset time is the time when stroke symptoms appear or the last known normal time of the patient (when it is an onset during sleep or the symptom onset time cannot be accurately obtained due to aphasia, impaired consciousness, etc.); ③ Confirmed diagnosis of ischemic stroke by CT or MRI of the brain within 2 weeks after symptom onset; * Local residents (residing for ≥6 months); ⑤ Patients who voluntarily participate in the study, have high compliance, and can sign the informed consent form; * Patients who own a smartphone or other smart devices.
Exclusion criteria
* Patients diagnosed with other cerebrovascular diseases (hemorrhagic stroke, transient ischemic attack, cerebral venous sinus thrombosis, etc.) or non-cerebrovascular diseases; * Known pregnant or lactating women, or those who tested positive on a pregnancy test before cluster randomization; * Patients with other conditions that may affect participation in the trial (e.g., refractory hypertension, severe aphasia, etc.); * Patients undergoing psychiatric/psychological treatment that may contaminate the results; ⑤ Patients with a life expectancy of less than one year (e.g., coexisting malignant tumors, severe cardiopulmonary diseases, etc.); ⑥ Patients already participating in other interventional clinical studies that may influence the outcome assessment; ⑦ Patients for whom the investigator deems unsuitable for participation in this study or who may pose significant risks to the patients (e.g., cognitive impairment preventing understanding and/or compliance with the study procedures and/or follow-up).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1-year recurrence rate of stroke | Intervention at the 1-year |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Cardiovascular system function indicators | Baseline; Intervention at 3-month, 6-month, 9-month and 1-year | Such as blood pressure, various electrocardiogram indicators and other examination results that can reflect cardiovascular function |
| Laboratory examination | Baseline; Intervention at 3-month, 6-month, 9-month and 1-year | Such as results of laboratory tests including lipid profiles, blood glucose, coagulation, and other laboratory indicators. |
| Modified Rankin Scale | Baseline; Intervention at 3-month, 6-month, 9-month and 1-year | The Modified Rankin Scale (mRS) is a scale used to assess the neurological recovery status and disability level in stroke patients. The scale ranges from zero to six, divided into seven levels, with higher grades indicating worse conditions. |
| European five-dimensional five-level Health Scale score | Baseline; Intervention at 3-month, 6-month, 9-month and 1-year | The scale includes five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, with each dimension containing five levels. It also includes a 0-100 scale, where a lower score indicates worse condition. |
| Risk perception scale of stroke recurrence | Baseline; Intervention at 3-month, 6-month, 9-month and 1-year | The scale uses a Likert three-point scoring method, assigning values of 1, 2, and 3 for the responses disagree, uncertain, and agree, respectively. A higher score indicates a higher level of perceived ability. |
| 3-month, 6-month, 9-month recurrence rate of stroke | Intervention at 3-month, 6-month, 9-month | — |
| Stroke health literacy score | Baseline; Intervention at 3-month, 6-month, 9-month and 1-year | The scale uses a five-point scoring method, with a higher score indicating a higher level of stroke health literacy. |
| Health status score | Baseline; Intervention at 3-month, 6-month, 9-month and 1-year | Such as barthel index (BI) and other scoring scales for evaluating patients' disease recovery, physical condition and other abilities |
| System usability scale | Intervention at 3-month, 6-month, 9-month and 1-year | — |
| Environmental temperature health risk perception assessment 1uestionnaire | Baseline; Intervention at 3-month, 6-month, 9-month and 1-year | Here are multiple questions related to environmental risk factors and health risks, each using a 0-100 scale where a higher score indicates greater understanding |
Other
| Measure | Time frame |
|---|---|
| Incidence of adverse cerebrovascular events | Intervention at the 1-year |
Contacts
Primary ContactJunwei Hao
Outcome results
None listed